Feb 11, 2016 at 16:56 | Source: PTI
Meanwhile, the public sector lender posted a net loss of Rs 1,505.58 crore for the quarter ended December 2015, mainly on account of higher provisioning for bad loans.
Feb 11, 2016 at 16:40 | Source: PTI
The approval is for Levofloxacin in 5 percent Dextrose injection in the strengths of 250 mg/50 ml, 500 mg/100 ml, and 750 mg/150 ml, single use containers, Aurobindo Pharma said in a BSE filing.
Feb 11, 2016 at 11:40 | Source: PTI
Once the deal is complete, Nippon Life Insurance would have 49 percent stake in the company, the maximum ownership allowed for a foreign player in a domestic private insurer.
Feb 08, 2016 at 11:30 | Source: PTI
The company added the commercial launch of the product is planned for the coming quarter.
Feb 05, 2016 at 20:12 | Source: PTI
Mahindra AMC, a wholly-owned subsidiary of Mahindra and Mahindra Financial Services (MMFS), got the regulator's nod on February 4
Feb 05, 2016 at 14:22 | Source: PTI
Mahindra AMC, a wholly-owned subsidiary of Mahindra & Mahindra Financial Services (MMFS), got the regulator's nod on February 4.
Feb 05, 2016 at 12:15 | Source: Moneycontrol.com
"Board of directors, on February 4, approved company's proposal to manufacture and sell set top boxes and allied products in India," the business networking solutions provider said in its filing.
Feb 04, 2016 at 15:12 | Source: PTI
"Maharashtra Governor C Vidyasagar Rao today gave his sanction to CBI to prosecute former Chief Minister of Maharashtra Ashok Chavan, under section 197 of CrPC, for offences under sections 120-B (conspiracy) and 420 (cheating) of IPC in the Adarsh Cooperative Housing Society case," an official in the Governor's office said.
Feb 03, 2016 at 14:28 | Source: PTI
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Isosulfan Blue injection 1 percent (50 mg/5 mL) single-dose vials, Aurobindo Pharma said in a statement.
Feb 03, 2016 at 11:28 | Source: Moneycontrol.com
This is third approval received by the company in the last two days. Yesterday, the company had received two approvals from USFDA to manufacture and market Celecoxib Capsules and Levetiracetam Injection USP.